SCHEMBL30131990

SCHEMBL30131990

COCOc1cc(Cl)ccc1-c1cnc(SC)nn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.35
PIK3CA P42336 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
MAPK10 P53779 1/20 0.35
HSP90AB1 P08238 2/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 5/20 0.34
TDP1 Q9NUW8 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 1/20 0.34
EGFR P00533 2/20 0.33
LMNA P02545 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C19 P33261 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21412242 1.00 MAPK1 (0.35) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL24248699 0.84 HSP90AA1 (0.37) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL22658916 0.81 PLAU (0.32) MAPT
SCHEMBL21412269 0.79 PTGDR2 (0.37) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL30131949 0.79 PTGDR2 (0.37) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL21412239 0.78 DGAT1 (0.36)
SCHEMBL30132046 0.78 EGFR (0.37) EGFR
SCHEMBL30132080 0.78 DGAT1 (0.36)
SCHEMBL25885043 0.78 EGFR (0.37) EGFR
SCHEMBL24253470 0.78 HSP90AA1 (0.38) MAPK1PIK3CAMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112203653-B Compounds for the treatment of huntington's disease PTC医疗公司 2024-08-16 CN disclosed
CN-115768762-A Compounds for the treatment of huntington's disease PTC医疗公司 2023-03-07 CN disclosed
EP-4132923-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2023-02-15 EP disclosed